Post-market Observational Study Zenith® t-Branch™

Cook Group Incorporated80 enrolled

Overview

The Zenith® t-Branch™ Thoracoabdominal Endovascular Graft Study is a post-market observational study to evaluate the performance of the Zenith® t-Branch™ in the treatment of thoracoabdominal aortic aneurysms in routine care.

Both retrospective and prospective patients will be enrolled

Study Type

OBSERVATIONAL

Enrollment

Conditions

Aortic Aneurysm Thoracoabdominal

Interventions

Zenith® t-Branch™ Thoracoabdominal Endovascular GraftDEVICE

Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guide the study device(s) into place in the aorta.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Treated with the off-the-shelf Zenith® t-Branch™ Thoracoabdominal Endovascular Graft * Signed informed consent Exclusion Criteria: * Inability or refusal to give informed consent by the patient or a legally authorized representative

Locations (3)

Universitäts Krankenhaus Eppendorf

Hamburg, Germany

St. Franziscus Hospital-GmbH

Münster, Germany

Skaane University Hospital

Malmo, Sweden

Outcomes

Primary Outcomes

Rate of mortality and morbidity

Time frame: 30 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.